Introduction:
The global pandemic caused by a novel coronavirus, termed “severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)”, emerged in Hubei province in China in December 2019. Follow on to this, the first official announcement of a diagnosed patient with coronavirus disease 2019 (COVID-19) in Iran was made on February 19, 2020. (1). As of June 26, a total of 2 020 217 724 diagnosed patients had been confirmed via laboratory assessments, and 177 852 patients had recovered or had been discharged from hospitals. This surely stretched thin the provision of healthcare on different healthcare sectors including cardiovascular surgery. The impact of this is still evolving despite resuming limited capacity to provide service to our cohort at large. The actual after-math from this has not been concluded. Hence, in this review we will reflect on the restructuring the pandemic virus has afflicted and its virulence on multilayered in our healthcare system.